Margo Georgiadis is a CEO-partner at Flagship Pioneering and co-founder and CEO of Montai Health, an AI platform company enabling the predictable discovery of breakthrough small molecule medicines to treat and preempt chronic disease. In these roles, Georgiadis brings extensive expertise in technological innovation and high-performance business transformation and leverages her artificial intelligence and machine learning experience to advance biotech innovation. In this presentation and conversation with Stanford adjunct lecturer Ravi Belani, Georgiadis shares frameworks that Flagship uses to develop deep tech companies and her approach to addressing the challenges of drug discovery.
Related
Ali Ghodsi,
Databricks
Lessons from a Large Founding Team [Entire Talk]
Building a successful company with a large founding team requires trust and a CEO who is willing to make hard decisions.
Ali Ghodsi,
Databricks
Lessons from a Large Founding Team [Entire Talk]
Building a successful company with a large founding team requires trust and a CEO who is willing to make hard decisions.
Sam Altman,
OpenAI
The Possibilities of AI [Entire Talk]
AI opportunities are just beginning. The future holds risks and rewards.
Sam Altman,
OpenAI
The Possibilities of AI [Entire Talk]
AI opportunities are just beginning. The future holds risks and rewards.
Qasar Younis,
Applied Intuition
Radically Pragmatic Insights [Entire Talk]
Becoming a successful entrepreneur requires more than ambition.
Qasar Younis,
Applied Intuition
Radically Pragmatic Insights [Entire Talk]
Becoming a successful entrepreneur requires more than ambition.
